Jeffrey M. Leiden, Executive Chairman at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 18,022 shares at $419.04 ($7.6M) on 2024-02-14, disclosed to the SEC on 2024-02-16.
Scheduled sale ($7.6M) by Executive Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $419.04 | 4,356 | $1.8M | 24.2% |
| 2 | $419.04 | 4,356 | $1.8M | 24.2% |
| 3 | $419.16 | 4,655 | $2.0M | 25.8% |
| 4 | $419.16 | 4,655 | $2.0M | 25.8% |
| Total | $419.10 avg | 18,022 | $7.6M | 100% |
| Filing → |
| VRTX | SELL | 2025-11-17 | $64.1M | — | Filing → |
| VRTX | SELL | 2024-09-04 | $1.9M | — | Filing → |
| VRTX | SELL | 2024-02-14 | $2.8M | — | Filing → |